What is the growth forecast for the Factor IX Lyophilized Concentrate market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Factor IX Lyophilized Concentrate market?

Key drivers include rising hemophilia B prevalence and advancements in treatment options, fueling market growth.

What challenges does the Factor IX Lyophilized Concentrate market face?

Challenges include high treatment costs, limited access to healthcare, and stringent regulatory requirements.

Which regions are expected to lead the Factor IX Lyophilized Concentrate market?

North America and Europe are expected to dominate the market, driven by high healthcare expenditure.

Who are the top companies in the Factor IX Lyophilized Concentrate market?

Top companies include Biogen, CSL Behring, and Pfizer, offering a range of treatment options.

What future opportunities exist in the Factor IX Lyophilized Concentrate market?

Emerging markets and innovative technologies offer future opportunities, driving the future outlook.

How will technology impact the Factor IX Lyophilized Concentrate market?

Advances in gene therapy and recombinant DNA technology will significantly impact the market, improving treatment efficacy.

What is the current regulatory landscape for the Factor IX Lyophilized Concentrate market?

The regulatory landscape is stringent, with FDA and EMA guidelines governing product approval and safety monitoring.

What does the future outlook for the Factor IX Lyophilized Concentrate market look like?

The future outlook is positive, with increasing demand and advancements in treatment options driving market growth.

Factor IX Lyophilized Concentrate Size, Share & Forecast Analysis 2025–2033

Factor IX Lyophilized Concentrate by Application (Hemophilia B, Acquired Coagulation Factor Deficiency), by Types (Beriplex, Profilnine, Octaplex, Prothromplex, Cofact, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $1052 million

CAGR: 12%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $1052 million

CAGR: 12%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Factor IX Lyophilized Concentrate Market Size | CAGR 12% Forecast 2033

Factor IX Lyophilized Concentrate Size, Share & Forecast Analysis 2025–2033

🏭 Healthcare🌍 Global

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $1052 million

CAGR: 12%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $1052 million

CAGR: 12%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Factor IX Lyophilized Concentrate Market Overview

The Factor IX Lyophilized Concentrate market refers to the industry involved in the production and distribution of lyophilized factor IX concentrates, which are used to treat hemophilia B. As the Factor IX Lyophilized Concentrate market size is anticipated to reach $1.4 billion by 2026, the growth outlook for this industry is promising, with a projected market forecast of 8% CAGR from 2026 to 2033, driving industry expansion. The scope of this market encompasses various synonyms, including factor IX deficiency treatment and hemophilia B management.

Loading chart…

The current Factor IX Lyophilized Concentrate market size is estimated to be around $1.1 billion. Key forces shaping the industry include technology shifts towards more advanced recombinant factor IX products, regulatory requirements for enhanced safety and efficacy, and consumer behavior driven by increasing awareness of hemophilia B treatment options. The largest region for this market is North America, while the fastest-growing region is expected to be Asia-Pacific. With a growth forecast of 8% CAGR and driven by macro drivers such as an increasing patient population and advancements in treatment options, the Factor IX Lyophilized Concentrate market is poised for significant industry expansion.

Report Overview

Report Attribute	Details
Market size value in 2025	1.05 billion
Revenue forecast in 2033	1.83 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	CSL Behring; Grifols; Octapharma; Prothya Biosolutions; Takeda
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Factor IX Lyophilized Concentrate market is poised for significant growth, driven by increasing demand for effective treatments of hemophilia B and other bleeding disorders. The market dynamics are shaped by various factors, including technological advancements, regulatory frameworks, and shifting consumer preferences.

Growth Drivers2 items

Advances in recombinant DNA technology have improved the production efficiency and purity of Factor IX Lyophilized Concentrate, leading to increased adoption and driving the Factor IX Lyophilized Concentrate market size

Growing awareness about bleeding disorders and expanding healthcare infrastructure in emerging economies are expected to fuel the growth forecast of the Factor IX Lyophilized Concentrate market

Restraints2 items

High production costs and stringent regulatory requirements may limit the growth of the Factor IX Lyophilized Concentrate market, making it challenging for new entrants to compete with established players

The risk of transmission of infectious diseases through plasma-derived products may also hinder the adoption of Factor IX Lyophilized Concentrate, particularly in regions with strict safety protocols

Opportunities2 items

The increasing prevalence of hemophilia B and other bleeding disorders in developing countries presents a significant opportunity for manufacturers to expand their presence in these markets and drive the Factor IX Lyophilized Concentrate market size

The development of novel recombinant products with improved efficacy and safety profiles may further boost the growth of the Factor IX Lyophilized Concentrate market, attracting new investments and partnerships

Challenges2 items

The Factor IX Lyophilized Concentrate market is highly competitive, with established players dominating the landscape, making it challenging for new entrants to gain market share and achieve significant growth forecast

Ensuring the consistent supply of high-quality plasma, a critical raw material for Factor IX Lyophilized Concentrate production, is a significant challenge, particularly in regions with limited plasma collection infrastructure

Market Segmentation

Loading chart…

The Application segment of the Factor IX Lyophilized Concentrate market refers to the various uses of the product in the medical field. This segment is crucial in understanding the Factor IX Lyophilized Concentrate segmentation as it highlights the different areas where the product is applied, such as hemophilia B treatment and research purposes. The application segment contributes significantly to the overall market size, as it directly impacts the demand for the product.

The Types segment of the Factor IX Lyophilized Concentrate market is further divided into subtypes, including [object Object] and [object Object]. This segment is essential in market taxonomy, as it provides a detailed classification of the product based on its characteristics, such as concentration and purity. The types segment plays a vital role in determining the market size, as different types of products cater to various customer needs and preferences.

Factor IX Lyophilized Concentrate Segmentation Breakdown10 items

Application

Hemophilia B

Acquired Coagulation Factor Deficiency

Types

Beriplex

Profilnine

Octaplex

Prothromplex

Cofact

Other

Regional Insights

Loading chart…

The Factor IX Lyophilized Concentrate market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of Factor IX Lyophilized Concentrate, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and established infrastructure. In Europe, drivers include regional forecast indicating a steady growth rate, strong policies supporting research and development, and a significant investment in the healthcare sector. Asia Pacific's growth is driven by a large and growing population, increasing adoption of advanced healthcare technologies, and strategic investments by key market players.

Latin America and Middle East & Africa are also expected to contribute to the Factor IX Lyophilized Concentrate market growth, with key drivers including government policies supporting healthcare development, growing demographics, and increasing investment in healthcare infrastructure. However, these regions are expected to account for a smaller share of the market, with Latin America at around 10% and Middle East & Africa at approximately 5%.

Competitive Landscape

The Factor IX Lyophilized Concentrate market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. The Factor IX Lyophilized Concentrate competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships to maintain their market position, while local companies concentrate on regional expansion and competitive pricing.

Companies in this market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Common competitive differentiation factors include technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To stay competitive, companies must balance their strategic focus with the need to adapt to changing market conditions.

CSL Behring: regional expansion

Grifols: vertical integration

Octapharma: premium pricing

Prothya Biosolutions: OEM tie-ups

Takeda: innovation pipeline

Takeda: local manufacturing

Key Factor IX Lyophilized Concentrate Companies5 items

CSL Behring

Grifols

Octapharma

Prothya Biosolutions

Takeda

Market Ecosystem

The Factor IX Lyophilized Concentrate ecosystem encompasses a complex network of participants, spanning upstream, midstream, and downstream segments. It involves technology providers and suppliers, integrators, channels, and end users, all of which contribute to the creation and capture of value. Understanding the Factor IX Lyophilized Concentrate ecosystem is crucial for navigating the intricate relationships between these stakeholders and identifying opportunities for growth and improvement.

Raw material suppliers — providing critical components

OEMs/manufacturers — producing Factor IX Lyophilized Concentrate

Distributors/channel partners — facilitating product delivery

Service providers/after-sales — offering support and maintenance

End users/buyers — administering the concentrate to patients

Regulators/standards bodies — establishing guidelines and approvals

Data/analytics providers — informing market trends and research

Value flows through the ecosystem as participants interact and exchange goods, services, and information. Control points, such as regulatory bodies and key manufacturers, influence adoption and shape the market landscape. Dependency risks, including input constraints and standards compliance, can create bottlenecks and impact the ecosystem's overall efficiency. Furthermore, switching costs, partnerships, and interoperability requirements can affect the flexibility and responsiveness of ecosystem participants, ultimately influencing the value chain analysis and the ecosystem's ability to adapt to regional differences and diverse market conditions.

Recent Industry Insights

The Factor IX Lyophilized Concentrate industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have focused on enhancing product distribution networks and expanding market reach. Notably, mergers and acquisitions have led to consolidation, resulting in a more streamlined industry landscape. Furthermore, innovative product launches have improved treatment options for patients, driven by advancements in technology.

Regulatory changes have also played a crucial role in shaping the industry, with updated guidelines influencing manufacturing processes and quality control. A shift in consumer trends towards personalized medicine has prompted companies to invest in research and development, catering to specific patient needs. Additionally, funding rounds and expansions have enabled companies to scale up production and explore new markets, ultimately driving growth in the Factor IX Lyophilized Concentrate market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Factor IX Lyophilized Concentrate market outlook. The market exhibits moderate attractiveness due to the growing demand for hemophilia B treatment options. The competitive intensity is relatively high, with key players investing in research and development to improve product efficacy and safety. The long-term outlook is promising, driven by the increasing prevalence of hemophilia B and advancements in _gene therapy_. However, the innovation landscape is evolving, with a focus on developing more convenient and cost-effective treatment options.

The demand-supply balance is expected to remain stable, with manufacturers expanding their production capacities to meet the growing demand. Key risk factors include _regulatory challenges_ and _supply chain disruptions_. Overall, the Factor IX Lyophilized Concentrate market is poised for growth, driven by the increasing adoption of prophylactic treatment regimens and the expanding patient population.

12 items

1. Executive Summary

2. Factor IX Lyophilized Concentrate Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Factor IX Lyophilized Concentrate Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Factor IX Lyophilized Concentrate Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Factor IX Lyophilized Concentrate Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Factor IX Lyophilized Concentrate Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Factor IX Lyophilized Concentrate Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Factor IX Lyophilized Concentrate Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Factor IX Lyophilized Concentrate Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Factor IX Lyophilized Concentrate Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Factor IX Lyophilized Concentrate Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Factor IX Lyophilized Concentrate Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Factor IX Lyophilized Concentrate Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Factor IX Lyophilized Concentrate Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Factor IX Lyophilized Concentrate Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Factor IX Lyophilized Concentrate Market Competition by Key Manufacturers

9.1. Global Factor IX Lyophilized Concentrate Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Factor IX Lyophilized Concentrate: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. CSL Behring

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Grifols

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Octapharma

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Prothya Biosolutions

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Takeda

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Factor IX Lyophilized Concentrate Market

Figure 4: Global Factor IX Lyophilized Concentrate Market: Drivers

Figure 5: Global Factor IX Lyophilized Concentrate Market: Challenges

Figure 6: Global Factor IX Lyophilized Concentrate Market: Trends

Figure 7: Global Factor IX Lyophilized Concentrate Market: Opportunity

Figure 8: Global Factor IX Lyophilized Concentrate Market: Restraint

Figure 9: Global Factor IX Lyophilized Concentrate Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Factor IX Lyophilized Concentrate Market Value (USD Million) By Region

Figure 19: Global Factor IX Lyophilized Concentrate Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Factor IX Lyophilized Concentrate Market Value (USD Million) By Region

Figure 27: Global Factor IX Lyophilized Concentrate Market Share (%) By: Regions (2032)

Figure 28: Global Factor IX Lyophilized Concentrate Market Volume (K) By Region

Figure 29: Global Factor IX Lyophilized Concentrate Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Factor IX Lyophilized Concentrate Market Value (USD Million) By Region

Figure 37: Global Factor IX Lyophilized Concentrate Market Share (%) By: Regions (2032)

Figure 38: Global Factor IX Lyophilized Concentrate Market Volume (K) By Region

Figure 39: Global Factor IX Lyophilized Concentrate Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

105 items

Table 1: Market Segmentation Analysis

Table 2: Global Factor IX Lyophilized Concentrate Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Factor IX Lyophilized Concentrate Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Factor IX Lyophilized Concentrate Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Factor IX Lyophilized Concentrate Market Value (USD Million) By Region

Table 14: Global Factor IX Lyophilized Concentrate Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Factor IX Lyophilized Concentrate Market Volume (K) By Region

Table 31: Global Factor IX Lyophilized Concentrate Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Factor IX Lyophilized Concentrate Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Factor IX Lyophilized Concentrate Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Factor IX Lyophilized Concentrate Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: CSL Behring Basic Information And Sales Area

Table 52: CSL Behring. Products Portfolio

Table 53: Grifols Basic Information And Sales Area

Table 54: Grifols. Products Portfolio

Table 55: Octapharma Basic Information And Sales Area

Table 56: Octapharma. Products Portfolio

Table 57: Prothya Biosolutions Basic Information And Sales Area

Table 58: Prothya Biosolutions. Products Portfolio

Table 59: Takeda Basic Information And Sales Area

Table 60: Takeda. Products Portfolio

Table 61: Global Market Value (USD Million) (2025-2032) By Application

Table 62: Global Market Share (%) By Application (2032)

Table 63: Global Market Value (USD Million) (2025-2032) By Types

Table 64: Global Market Share (%) By Types (2032)

Table 65: Global Market Volume (K) (2025-2032) By Application

Table 66: Global Market Share (%) By Application (2032)

Table 67: Global Market Volume (K) (2025-2032) By Types

Table 68: Global Market Share (%) By Types (2032)

Table 69: Global Factor IX Lyophilized Concentrate Market Value (USD Million) By Region

Table 70: Global Factor IX Lyophilized Concentrate Market Share (%) By Region (2025-2032)

Table 71: North America Market Value (USD Million) (2025-2032) By Country

Table 72: North America Market Value (USD Million) (2025-2032) By Application

Table 73: North America Market Value (USD Million) (2025-2032) By Types

Table 74: Europe Market Value (USD Million) (2025-2032) By Country

Table 75: Europe Market Value (USD Million) (2025-2032) By Application

Table 76: Europe Market Value (USD Million) (2025-2032) By Types

Table 77: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 80: South America Market Value (USD Million) (2025-2032) By Country

Table 81: South America Market Value (USD Million) (2025-2032) By Application

Table 82: South America Market Value (USD Million) (2025-2032) By Types

Table 83: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 86: Global Factor IX Lyophilized Concentrate Market Volume (K) By Region

Table 87: Global Factor IX Lyophilized Concentrate Market Share (%) By Region (2025-2032)

Table 88: North America Market Volume (K) (2025-2032) By Country

Table 89: North America Market Volume (K) (2025-2032) By Application

Table 90: North America Market Volume (K) (2025-2032) By Types

Table 91: Europe Market Volume (K) (2025-2032) By Country

Table 92: Europe Market Volume (K) (2025-2032) By Application

Table 93: Europe Market Volume (K) (2025-2032) By Types

Table 94: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 95: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 96: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 97: South America Market Volume (K) (2025-2032) By Country

Table 98: South America Market Volume (K) (2025-2032) By Application

Table 99: South America Market Volume (K) (2025-2032) By Types

Table 100: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 101: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 102: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 103: Research Programs/Design For This Report

Table 104: Key Data Information From Secondary Sources

Table 105: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Factor IX Lyophilized Concentrate Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.05 billion
Revenue forecast in 2033	1.83 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	CSL Behring; Grifols; Octapharma; Prothya Biosolutions; Takeda
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options